Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2021 May 5:76:e1987.
doi: 10.6061/clinics/2021/e1987. eCollection 2021.

A randomized controlled study on an integrated approach to prevent and treat re-adhesion after transcervical resection of moderate-to-severe intrauterine adhesions

Affiliations
Randomized Controlled Trial

A randomized controlled study on an integrated approach to prevent and treat re-adhesion after transcervical resection of moderate-to-severe intrauterine adhesions

Li-Zhen Pan et al. Clinics (Sao Paulo). .

Abstract

Objectives: This study aims to compare the clinical efficacy of an integrated approach to prevent and treat the recurrence of moderate-to-severe intrauterine adhesions (IUA) after hysteroscopic transcervical resection of adhesion (TCRA).

Methods: The study included a total of 70 patients with moderate-to-severe IUAs who underwent TCRA. Patients were randomly divided into two groups: treatment group (n=35) and control group n=35). In the treatment group, patients underwent balloon uterine stent placement and artificial cycle as well as received intrauterine perfusion of Danshen injection and oral Chinese medicine. In the control group, patients underwent balloon uterine stent placement and artificial cycle as well as received hyaluronic acid sodium and intrauterine device (IUD). Follow-up was performed after treatment of uterine cavity, menstruation and pregnancy.

Results: After 3 months of treatment, we observed a significantly lower rate of intrauterine re-adhesion (45.71% versus 77.14%, p=0.044) and significantly higher clinical efficiency (82.86% versus 77.14%, p=0.025) in the treatment group than those in the control group. After 6 months of treatment, we observed a significantly higher clinical efficiency in the treatment group than that in the control group (88.57% versus 68.57%, p=0.039). During the follow-up period, the pregnancy rate was 45.71% and 37.14% in the treatment group and control group, respectively, although the difference was not statistically significant (p=0.628).

Conclusions: After surgical management of IUA, the integrated treatment combining a uterus stent placement and artificial cycle with Danshen injection and oral Chinese medicine can improve the condition of menstruation, and prevent and treat recurrence of IUA.

PubMed Disclaimer

Conflict of interest statement

No potential conflict of interest was reported.

Similar articles

Cited by

References

    1. Mentula M, Männistö J, Gissler M, Heikinheimo O, Niinimäki M. Intrauterine adhesions following an induced termination of pregnancy: a nationwide cohort study. BJOG. 2018;125(11):1424–31. doi: 10.1111/1471-0528.15216. - DOI - PubMed
    1. Thomson AJ, Abbott JA, Deans R, Kingston A, Vancaillie TG. The management of intrauterine synechiae. Curr Opin Obstet Gynecol. 2009;21(4):335–41. doi: 10.1097/GCO.0b013e32832e07fc. - DOI - PubMed
    1. Chinese Society of Obstetrics and Gyneocology; Chinese Medical Association [Expert consensus on the diagnosis and management of intrauterine adhesions in China] Zhonghua Fu Chan Ke Za Zhi. 2015;50(12):881–7. - PubMed
    1. Peng X, Li T, Zhao Y, Guo Y, Xia E. Safety and Efficacy of Amnion Graft in Preventing Reformation of Intrauterine Adhesions. J Minim Invasive Gynecol. 2017;24(7):1204–10. doi: 10.1016/j.jmig.2017.08.005. - DOI - PubMed
    1. Azizi R, Aghebati-Maleki L, Nouri M, Marofi F, Negargar S, Yousefi M. Stem cell therapy in Asherman syndrome and thin endometrium: Stem cell- based therapy. Biomed Pharmacother. 2018;102:333–43. doi: 10.1016/j.biopha.2018.03.091. - DOI - PubMed

Publication types

Substances